English
Back
Download
Log in to access Online Inquiry
Back to the Top

Watching

$Coherus BioSciences (CHRS.US)$ im watching closely for this (  Coherus anticipates demand will continue to rise with significantly improved commercial and Medicare Advantage formulary coverage in the fourth quarter of 2023 and in 2024.)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
Translate
Report
5542 Views
Comment
Sign in to post a comment
5248
Followers
23
Following
76K
Visitors
Follow